Thursday, January 8, 2009 - 1:08PM EST

Drug Therapy

11. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.

Author
Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M;
Institution
Institute for Endocrinology and Diabetes, National Center of Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel.
Journal
Pediatrics. 2006 Jun;117(6):2126-31.
Abstract URL
Click here to view abstract

12. Predictors of glycemic control on insulin pump therapy in children and adolescents with type I diabetes.

Author
Nabhan ZM; Rardin L; Meier J; Eugster EA; Dimeglio LA;
Institution
Section of Pediatric Endocrinology and Diabetology, Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
Journal
Diabetes Res Clin Pract. 2006 Dec;74(3):217-21. Epub 2006 May 15.
Abstract URL
Click here to view abstract

13. Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.

Author
Karaguzel G; Satilmis A; Akcurin S; Bircan I;
Institution
Pediatric Endocrinolog, Akdeniz University, School of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Antalya, Turkey. gulaykg@yahoo.com
Journal
Diabetes Res Clin Pract. 2006 Oct;74(1):15-20. Epub 2006 Apr 18.
Abstract URL
Click here to view abstract

14. Use of pramlintide: the patient's perspective.

Author
Want L;
Institution
MedStar Research Institute, 650 Pennsylvania Ave. SE #50, Washington, DC 20003, USA.
Journal
Diabetes Educ. 2006 May-Jun;32 Suppl 3:111S-118S.
Abstract URL
Click here to view abstract

15. Amylin replacement therapy in patients with type 1 diabetes.

Author
Edelman SV; Caballero L;
Institution
University of California, San Diego, Veterans Affairs Medical Center, 3550 La Jolla Village Drive 111G, San Diego, CA 92161, USA. svedelman@vapop.ucsd.edu
Journal
Diabetes Educ. 2006 May-Jun;32 Suppl 3:119S-127S.
Abstract URL
Click here to view abstract

16. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.

Author
Juliusson PB; Graue M; Wentzel-Larsen T; Sovik O;
Institution
Department of Paediatrics, Haukeland University Hospital, Bergen, Norway. pjul@helse-bergen.no
Journal
Acta Paediatr. 2006 Nov;95(11):1481-7.
Abstract URL
Click here to view abstract

17. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.

Author
Eugster EA; Francis G;
Institution
Section of Pediatric Endocrinology/Diabetology, Riley Hospital for Children, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. eeugster@iupui.edu
Journal
Pediatrics. 2006 Oct;118(4):e1244-9.
Abstract URL
Click here to view abstract

18. Unrecognised hypoglycaemia in children and adolescents with type 1 diabetes using the continuous glucose monitoring system: prevalence and contributors.

Author
Wiltshire EJ; Newton K; McTavish L;
Institution
Department of Paediatrics and Child Health, Wellington School of Medicine and Health Sciences, Wellington South, New Zealand. esko.wiltshire@otago.ac.nz
Journal
J Paediatr Child Health. 2006 Dec;42(12):758-63.
Abstract URL
Click here to view abstract
Pages: 1 2 3